Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity.

Karim, Gres; Reddy, Megha; Mobin, Navim; Weisberg, Ilan; Dinani, Amreen.

Afiliação

Karim G; Division of Gastroenterology and Hepatology, New York Presbyterian-Brooklyn Methodist, Brooklyn, New York, USA.
Reddy M; Department of Internal Medicine, New York Presbyterian-Brooklyn Methodist, Brooklyn, New York, USA.
Mobin N; Division of Gastroenterology and Hepatology, New York Presbyterian-Brooklyn Methodist, Brooklyn, New York, USA.
Weisberg I; Division of Gastroenterology and Hepatology, New York Presbyterian-Brooklyn Methodist, Brooklyn, New York, USA.
Dinani A; Division of Gastroenterology, Duke University Hospital, 40 Duke Medicine Cir, Durham, North Carolina, USA.

Clin Liver Dis (Hoboken) ; 23(1): e0096, 2024.

Article em En | MEDLINE | ID: mdl-38283303

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article